Molecular Biomarkers Associated with Early-Onset Symptomatic Intracranial Atherosclerosis

References

• Ma YH, Leng XY, Dong Y, et al. Risk factors for intracranial atherosclerosis: a systematic review and meta-analysis. Atherosclerosis. 2019;281:71–77.30658194
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao X, Liu L, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study. Stroke. 2014;45(3):663–669.24481975
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Vadikolias K, Heliopoulos I, et al. Prevalence of symptomatic intracranial atherosclerosis in Caucasians: a prospective, multicenter, transcranial Doppler study. J Neuroimaging. 2014;24(1):11–17.22818110
   PubMed Web of Science ®Google Scholar
• Battistella V, Elkind M. Intracranial atherosclerotic disease. Eur j Neurol. 2014;21(7):956–962.24612339
   PubMed Web of Science ®Google Scholar
• Massberg S, Brand K, Grüner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196(7):887–896.12370251
   PubMed Web of Science ®Google Scholar
• Ritz K, Denswil NP, Stam OCG, et al. Cause and mechanisms of intracranial atherosclerosis. Circulation. 2014;130(16):1407–1414.25311618
   PubMed Web of Science ®Google Scholar
• Park JH, Kwon HM, Roh JK. Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis. Eur J Neurol. 2007;14(4):379–386.17388984
   PubMed Web of Science ®Google Scholar
• Celik A, Ozcetin M, Celikyay ZRY, et al. Evaluation of possible subclinical atherosclerosis in adolescents with a family history of premature atherosclerosis. Atherosclerosis. 2012;222(2):537–540.22503547
   PubMed Web of Science ®Google Scholar
• Maaijwee NA, Rutten-Jacobs LC, Schaapsmeerders P, et al. Ischaemic stroke in young adults: risk factors and long-term consequences. Nat Rev Neurol. 2014;10(6):315–325.24776923
   PubMed Web of Science ®Google Scholar
• Terni E, Giannini N, Brondi M, et al. Genetics of ischaemic stroke in young adults. BBA Clin. 2014;3:96–106.26672892
   PubMedGoogle Scholar
• Wang Y, Meng R, Liu G, et al. Intracranial atherosclerotic disease. Neurobiol Dis. 2019;124:118–132.30439443
   PubMed Web of Science ®Google Scholar
• Kazmierski R, Guzik P, Ambrosius W, et al. Predictive value of white blood cell count on admission for in-hospital mortality in acute stroke patients. Clin Neurol Neurosurg. 2004;107(1):38–43.15567551
   PubMed Web of Science ®Google Scholar
• Yildirim T, Akin F, Altun I, et al. Platelet indices and stroke. Ren Fail. 2018;40(1):265.29619869
   PubMed Web of Science ®Google Scholar
• Wu MD, Atkinson TM, Lindner JR. Platelets and von Willebrand factor in atherogenesis. Blood. 2017;129(11):1415–1419.28174163
   PubMed Web of Science ®Google Scholar
• Nagy B, Miszti-Blasius K, Kerenyi A, et al. Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation. Curr Med Chem. 2012;19(4):518–531.22204330
   PubMed Web of Science ®Google Scholar
• Lapenna D, Ciofani G, Ucchino S, et al. Serum albumin and biomolecular oxidative damage of human atherosclerotic plaques. Clin Biochem. 2010;43(18):1458–1460.20807525
   PubMed Web of Science ®Google Scholar
• Canpolat U, Turak O, Özcan F, et al. Impact of free thyroxine levels and other clinical factors on bare metal stent restenosis. Arch Endocrinol Metab. 2017;61(2):130–136.28489156
   PubMed Web of Science ®Google Scholar
• Kittner SJ, Singhal AB. Premature atherosclerosis: a major contributor to early-onset ischemic stroke. Neurology. 2013;80(14):1272–1273.23468547
   PubMed Web of Science ®Google Scholar
• Kamimura T, Okazaki S, Morimoto T, et al. Prevalence of RNF213 p.R4810K variant in early-onset stroke with intracranial arterial stenosis. Stroke. 2019;50(6):1561–1563.31060437
   PubMed Web of Science ®Google Scholar
• Neurology C, Society C. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018. Chinese J Neurol. 2018;51:666–682.
   Google Scholar
• Barnett HJM, Taylor DW, Haynes RB, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325(7):445–453.1852179
   PubMed Web of Science ®Google Scholar
• Vbiagele B, Lynn MJ, Saver JL, et al. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2007;24(2–3):283–288.17646693
   PubMed Web of Science ®Google Scholar
• Ortega E, Gilabert R, Nuñez I, et al. White blood cell count is associated with carotid and femoral atherosclerosis. Atherosclerosis. 2012;221(1):275–281.22244768
   PubMed Web of Science ®Google Scholar
• Seizer P, May AE. Therapeutic potential and strategies against leukocyte-platelet interaction in atherosclerosis. Curr Vasc Pharmacol. 2012;10(5):550–554.22338569
   PubMed Web of Science ®Google Scholar
• Sekitani Y, Hayashida N, Kadota K, et al. White blood cell count and cardiovascular biomarkers of atherosclerosis. Biomarkers. 2010;15(5):454–460.20507253
   PubMed Web of Science ®Google Scholar
• Aukrust P, Halvorsen B, Ueland T, et al. Activated platelets and atherosclerosis. Expert Rev Cardiovasc Ther. 2010;8(9):1297–1307.20828352
   PubMedGoogle Scholar
• Dotsenko O, Chaturvedi N, Thom SA, et al. Platelet and leukocyte activation, atherosclerosis and inflammation in European and South Asian men. J Thromb Haemost. 2007;5(10):2036–2042.17883700
   PubMed Web of Science ®Google Scholar
• Davis KA, Miyares MA, Dietrich E. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: a review of the evidence. Am J Health Syst Pharm. 2015;72(19):1623–1629.26386103
   PubMed Web of Science ®Google Scholar
• Yeung J, Li W, Holinstat M. Platelet signaling and disease: targeted therapy for thrombosis and other related diseases. Pharmacol Rev. 2018;70(3):526–548.29925522
   PubMed Web of Science ®Google Scholar
• Barrett TJ, Schlegel M, Zhou F. Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis. Sci Transl Med. 2019;11:517.
   Web of Science ®Google Scholar
• Lindemann S, Krämer B, Seizer P, Gawaz M. Platelets, inflammation and atherosclerosis. J Thromb Haemost. 2007;5(Suppl 1):203–211.17635728
   PubMed Web of Science ®Google Scholar
• Gerdes N, Seijkens T, Lievens D, et al. Platelet CD40 exacerbates atherosclerosis by transcellular activation of endothelial cells and leukocytes. Arterioscler Thromb Vasc Biol. 2016;36(3):482–490.26821950
   PubMed Web of Science ®Google Scholar
• Fukuyama K, Ichiki T, Takeda K, et al. Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone. Hypertension. 2003;41(3):598–603.12623965
   PubMed Web of Science ®Google Scholar
• Perrotta C, Buldorini M, Assi E, et al. The thyroid hormone triiodothyronine controls macrophage maturation and functions: protective role during inflammation. Am J Pathol. 2014;184(1):230–247.24215914
   PubMed Web of Science ®Google Scholar
• Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003;88(6):2438–2444.12788839
   PubMed Web of Science ®Google Scholar
• Bano A, Chaker L, Mattace-Raso FUS, et al. Thyroid function and the risk of atherosclerotic cardiovascular morbidity and mortality: the Rotterdam study. Circ Res. 2017;121(12):1392–1400.29089349
   PubMed Web of Science ®Google Scholar
• Shi Z, Zhang X, Chen Z, et al. Elevated thyroid autoantibodies and intracranial stenosis in stroke at an early age. Int J Stroke. 2014;9(6):735–740.24024979
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhou Y, Ding W, et al. TPO-Ab plays a role in arterial remodeling in patients with intracranial stenosis. Atherosclerosis. 2019;280:140–146.30513409
   PubMed Web of Science ®Google Scholar
• Azab B, Bibawy J, Harris K. Value of albumin-globulin ratio as a predictor of all-cause mortality after non-ST elevation myocardial infarction. Angiology. 2013;64(2):137–145.22345150
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cliff WJ, Schoefl GI, Higgins G. Plasma protein insudation as an index of early coronary atherogenesis. Am J Pathol. 1993;143(2):496–506.8342598
   PubMed Web of Science ®Google Scholar
• Kuipers F, Stroeve JH, Caron S, Staels B. Bile acids, farnesoid X receptor, atherosclerosis and metabolic control. Curr Opin Lipidol. 2007;18(3):289–297.17495603
   PubMed Web of Science ®Google Scholar
• Tsompanidi EM, Brinkmeier MS, Fotiadou EH, Giakoumi SM, Kypreos KE. HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis. Atherosclerosis. 2010;208(1):3–9.19595353
   PubMed Web of Science ®Google Scholar
• Gary T, Pichler M, Schilcher G, et al. Elevated blood urea nitrogen is associated with critical limb ischemia in peripheral arterial disease patients. Medicine. 2015;94(24):e948.26091458
   PubMed Web of Science ®Google Scholar
• Yang F, Tan HM, Wang H. Hyperhomocysteinemia and atherosclerosis. Sheng li Xue Bao. 2005;57(2):103–114.15830093
   PubMedGoogle Scholar